Condition: Post-ERCP Adverse Events · ERCP Complications · Sponsor: Air Force Military Medical University, China
Endoscopic retrograde cholangiopancreatography (ERCP) is a crucial minimally invasive technique for the diagnosis and treatment of biliary and pancreatic diseases. However, it remains technically demanding and carries a postoperative adverse event (AE) rate exceeding 10% (e.g., pancreatitis, bleeding, and perforation), which subsequently leads to prolonged length of stay (LOS) and increased healthcare costs. With the rapid acceleration of population aging, the clinical demand for ERCP among the elderly has surged. Although ERCP is generally considered safe for older adults, advanced age also increases the risk of ERCP-related AEs and prolonged LOS. While previous studies investigated the outcomes of ERCP in elderly patients, those studies were predominantly retrospective, accompanied by selection bias. Moreover, insufficient factors were included in those retrospective studies. Importantly, some aging-related parameters, such as frailty, functional reserve, cognitive and psychological status, were not included in previous studies. Therefore, the investigators conducted a prospective, multicenter cohort study aimed at investigating outcomes in elderly patients undergoing ERCP and comprehensive factors (patient-related, procedure-related, and geriatric factors) associated with adverse outcomes.
This description comes directly from the study's public registry record.
Yanglin Pan, M.D · 13991811225 · yanglinpan@hotmail.com
Always discuss trial participation with your own doctor first.
| Xiamen Hong'ai Hospital | Xiamen, Fujian, China | Recruiting |
| Xijing Hospital of Digestive Diseases | Xi'an, Shaanxi, China | Recruiting |
| The Second Affiliated Hospital of Air Force Military Medical University | Xi'an, Shaanxi, China | Recruiting |
| Department of Gastroenterology, 986 Hospital of Xijing Hospital, Fourth MilitaryMedical University | Xi'an, Shaanxi, China | Recruiting |
| Xi'an Honghui Hospital | Xi'an, Shaanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07568626